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ture and integrity of the pulmonary arteries and their
distal vascular bed only postponed by months the
inevitable death that previously had typically occurred
during the first few weeks of life. 
From these early lessons, Norwood distilled the
essential features of successful neonatal palliation of
aortic atresia and other forms of HLHS: (1) association
of the aorta directly with the right ventricle in a fashion
that guarantees unobstructed flow from the right ventri-
cle to the systemic circulation and growth potential for
the aorta, obviating the need for further aortic surgery;
(2) regulation of pulmonary blood flow to ensure prop-
er growth and development and maturation of the pul-
monary vasculature, to avoid the development of pul-
monary vascular obstructive disease, and to minimize
the volume load on the ventricle; and (3) establishment
of a large interatrial communication to avoid pulmonary
venous hypertension. Thus, in 1983 Norwood and his
associates1 described successful physiologic repair of
aortic atresia–HLHS by means of an initial palliation
based on these principles, followed by a modified
Fontan procedure.
Physiologic repair of HLHS has evolved from a 2-
staged operative strategy, which 10 to 15 years ago was
performed in a handful of centers in this country, to a 3-
staged operative strategy that is now performed at most
major pediatric cardiac surgery centers, not only in the
United States but in most parts of the world. The
immense value of interposing a second-stage proce-
dure, a hemi-Fontan or bidirectional superior cavopul-
monary anastomosis, rapidly became apparent.
Limiting the duration of the fragile palliated state to a
few months, combined with early reduction of the vol-
ume load of the single ventricle, has enabled many
more children to eventually undergo successful total
cavopulmonary connection. Some unresolved issues
remain regarding the optimal timing and exact technical
features of the eventual total cavopulmonary connec-
tion. Nonetheless, it is the initial palliative stage of sur-
gical reconstruction, and the ensuing months character-
ized by parallel systemic and pulmonary circulations,
that still pose the greatest challenges in the overall man-
agement scheme. 
Hypoplastic left heart syndrome (HLHS) is the most fre-quently encountered of the various congenital heart
malformations characterized by a single well-developed
ventricle. The introduction more than three decades ago
by Fontan and Kreutzer of operative strategies to separate
the systemic and pulmonary circulations in patients with
tricuspid atresia led to the recognition that all single-ven-
tricle anomalies could be managed in a similar fashion, at
least in theory. The unique challenge of aortic
atresia–HLHS was that the presence of systemic outflow
obstruction and thus ductal dependency of the systemic
circulation resulted in rapid and predictable hemodynam-
ic deterioration of neonates with this condition and
demanded an operative strategy considerably more ambi-
tious than merely regulating pulmonary blood flow by
means of either a pulmonary artery band or a systemic-
pulmonary shunt. The availability in the 1970s of
prostaglandins to ensure patency of the ductus arteriosus
was of major importance in the overall management of
neonates with HLHS. 
During the same era, numerous investigators and sur-
gical teams experimented with a host of innovative and
imaginative strategies to stabilize the circulation of
neonates with aortic atresia and related malformations.
In addition to the magnitude of the overall challenge,
two things became apparent: (1) separation of the sys-
temic and pulmonary circulations by atriopulmonary or
cavopulmonary connection could not be achieved suc-
cessfully in young infants because of the prohibitively
high pulmonary vascular resistance and (2) palliative
operative strategies that did not preserve the architec-
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In this issue of the Journal, Poirier and associates2
summarize the excellent results of their surgical efforts
with a challenging group of neonates and infants with
HLHS (80%) and other lesions with ductal dependency
of systemic blood flow (20%). As their methods pro-
duced an operative survival of 83%, those methods
merit careful study. The principal modification of the
stage I Norwood procedure that Dr Mee and his surgi-
cal team at the Cleveland Clinic espouse is the use of
only autologous tissue to reconstruct the aortic arch.
This differs from what the authors describe as the
“standard Norwood operation,” which includes the use
of homograft vascular tissue to augment the amalga-
mation of the native ascending aorta, the arch, and the
proximal main pulmonary trunk. In fact, the procedure
described in 1983 by Norwood’s group used only
autologous tissue to accomplish this amalgamation. 
Over the ensuing 17 years, a variety of materials have
been incorporated into the reconstruction, with homo-
graft vascular tissue proving to be the best choice on
the basis of availability, handling characteristics, and
hemostatic properties. Different surgeons may invoke
different rationales for the use of vascular patch mater-
ial in the stage I palliation. However, more than any-
thing else its use as described by Norwood allows for a
standardized operative approach to the neonate with
single-ventricle physiology and systemic ventricular
outflow obstruction, regardless of specific anatomic
details and regardless of the degree of hypoplasia of the
ascending aorta and the various elements of the arch.
As a result, many of Norwood’s pupils and protégés
have come to refer to the stage I palliative procedure as
the “omni” procedure, because of its universal applica-
bility. In this operation, the native aorta is incised along
its lesser curvature from a point well distal to ductal
entry into the thoracic aorta, along the lesser curve of
the aortic arch, and down the medial aspect of the
diminutive ascending aorta to a point directly opposite
the transected pulmonary trunk. The entire arch is aug-
mented with a shield-shaped gusset of cryopreserved
pulmonary artery homograft tissue. Proximally, the
ascending aorta is anastomosed in side-to-side fashion
to the proximal pulmonary trunk, and the amalgama-
tion is completed by suturing the homograft gusset to
the remainder of the circumference of the pulmonary
trunk. The anastomosis of the ascending aorta to the
pulmonary trunk is technically the most critical part.
When performed correctly, it leaves a very short seg-
ment of native ascending aorta to serve as the immedi-
ate pre–coronary arterial pathway. Repeated experience
with fashioning the homograft gusset results in an aor-
tic reconstruction that, while larger than normal proxi-
mally, looks very much like “an aortic arch.”
As Norwood did originally, Mee and his associates
have chosen to perform the entire reconstruction with
autologous tissue. They infer that this might optimize
aortic growth and avoid degeneration of patch material.
Thus, their modification of the Norwood procedure
consists of restructuring the arch by means of a com-
bined anastomosis of the proximal main pulmonary
artery to the arch and descending aorta without the use
of foreign material. In this regard, it is fundamentally
similar to the procedure described in 1995 by Fraser
and Mee3 and in the same year by Brawn and associ-
ates4 of Birmingham, United Kingdom. Both groups
have achieved noteworthy results with respect to early
survival, and the 83% hospital survival in the present
report compares very favorably with most contempo-
rary results. However, a careful analysis of the results
presented by Poirier and coworkers2 suggests that this
operative method may be less suitable for patients with
the tiny ascending aorta that is the hallmark of aortic
atresia, the most extreme and most common anatomic
subset of HLHS. 
The number of patients in this report with a truly
diminutive ascending aorta (less than 2.5 mm) corre-
sponds very closely to the number with aortic atresia.
They make up a bit more than one half of the total num-
ber of patients with HLHS, and the rates of early and
intermediate mortality for this group are 33% and 50%,
respectively. In recent cases, the authors appropriately
addressed the challenge of ensuring adequate coronary
blood flow through a series of three modifications to
the operative technique and expressed optimism with
respect to the procedure that has most recently evolved.
Yet early and intermediate mortality are not signifi-
cantly lower in the latter half of the series than in the
first half. By way of contrast, aortic atresia and small
size of the ascending aorta have not been identified as
risk factors for mortality in series from Philadelphia5
and Ann Arbor,6 wherein the technical features of stage
I palliation included lengthwise incision into the
ascending aorta and patch augmentation of the aortic
reconstruction. Other series with other operative tech-
niques have identified aortic atresia and small aortic
size as risk factors for mortality and have been corre-
lated with autopsy findings of myocardial ischemia and
pre-coronary stenosis.7,8
The palliated state of patients with HLHS is a period
of significant vulnerability. This is certainly in large
part a consequence of the abnormal physiology of
coronary blood flow in this state. There is considerable
diastolic runoff into the systemic–pulmonary artery
shunt. Fogel and associates9 used echocardiography
and Doppler flow studies to assess coronary blood flow
in patients with aortic atresia. After stage I palliation,
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coronary blood flow was predominantly during systole,
as compared with the predominance of diastolic coro-
nary blood flow in normal hearts. In addition, coronary
blood flow requirements in the palliated state consider-
ably exceed normal levels until the second-stage proce-
dure, when the volume load on the single ventricle is
reduced. Thus, the merit of technical modifications to
the Norwood stage I palliative procedure must be con-
sidered with respect to their influence on coronary
blood flow and its impact on survival, not only at the
time of initial palliation, but throughout the several
months of life that precede the second-stage procedure.
Intuitively, it is attractive to assume that the elimina-
tion of patch material in an aortic reconstruction may
be associated with a lower incidence of late aortic arch
obstruction. Nonviable patch material, even homograft
tissue, is not expected to grow. Curiously, nearly all
aortic arch obstruction after initial palliation of HLHS
is encountered in the first several months of life.10 This
is almost certainly related to the technical adequacy of
the reconstruction rather than non-growth of the aug-
mented aorta. Growth characteristics of the recon-
structed aortic arch after surgical treatment of HLHS
have been studied by Mahle and colleagues11 in
patients operated on a decade ago by Dr Norwood.
These echocardiographic studies demonstrate that
growth of the reconstructed aorta parallels growth seen
in normal subjects. Postmortem investigations in
Mahle’s study reveal that all of the growth of the recon-
structed aorta occurs in the native tissue that makes up
at least a portion of the circumference of the aorta at
every level. In angiographic studies done on patients 4
to 10 years after initial palliation, the aortic arch looks
like an aortic arch, although larger than normal proxi-
mally. At present, one can only speculate that similarly
satisfactory results will eventually be observed in
patients whose aortic reconstruction uses only autolo-
gous tissue. 
Although it is essential that we continue to refine the
strategies of operative management of HLHS, at the
heart of this issue is the question of whether Norwood’s
stage I palliative operation should be altered in ways
that may introduce new variables with respect to coro-
nary perfusion, particularly in patients with aortic atre-
sia and a truly diminutive ascending aorta. It is con-
ceivable that the most recent modifications of aortic
configuration described by Poirier and associates2 may
eliminate the problems with coronary insufficiency that
were encountered early in the series. It is important that
technical advances continue to be made both with
respect to preoperative, intraoperative, and postopera-
tive management of the abnormal physiologic state of
these patients and with respect to the surgical exercises
themselves. In the latter area, modifications such as
those proposed by Poirier and coworkers2 have among
their objectives the goal of reducing the potential
effects of cardiopulmonary bypass and circulatory
arrest. Further progress in these areas is expected to
contribute to the optimization not only of survival, but
also of functional and neurologic outcomes. Growth of
the surgically created pathways remains a considera-
tion and will be the subject of ongoing investigations.
The lessons learned in the surgical management of
HLHS not only have dramatically affected the lives of
children with this common heart malformation, but
also have contributed immensely to the successful
management of the entire spectrum of critical heart
malformations necessitating surgical intervention early
in life.
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